Wed Feb 19 10:40:00 UTC 2025: ## NEC Invests in US Healthcare Data Analytics Firm Aetion to Accelerate Real-World Evidence Use in Drug Development

**Tokyo, Japan – [Date of Release]** – NEC Corporation today announced an investment in Aetion, Inc., a leading US-based provider of healthcare data analytics platforms. This investment, made through NEC Orchestrating Future Fund, marks the beginning of a collaborative effort to leverage real-world data (RWD) and real-world evidence (RWE) for more efficient drug development.

Aetion’s platform, Aetion Evidence Platform (AEP), helps standardize and analyze RWD from diverse sources, producing reliable RWE to assess drug safety and efficacy. This addresses key challenges in RWD/RWE utilization, such as data quality and regulatory compliance. The platform is already used globally by pharmaceutical companies, regulatory authorities, insurance providers, and healthcare institutions.

NEC, with its existing healthcare and life sciences business, sees this partnership as a significant step towards solving healthcare challenges and creating new value. The collaboration aims to streamline the drug development process and potentially contribute to the creation of new therapies.

“Aetion’s work in supporting medical decision-making based on RWD/RWE aligns perfectly with our vision of contributing to personalized medicine,” stated [Name and Title at NEC]. “We expect this collaboration to accelerate the creation of new societal value.”

Jeremy Rassen, CEO and Co-founder of Aetion, echoed this sentiment, stating that the investment “validates the potential of our software to facilitate better decision-making in markets like Japan.” He expressed enthusiasm for the continued collaboration to improve global healthcare solutions.

The NEC Orchestrating Future Fund focuses on investing in startups leveraging cutting-edge technology to create new markets. This investment in Aetion reflects their commitment to supporting innovative approaches in next-generation healthcare. Both companies will now explore further collaborative opportunities in the RWD/RWE space.

Read More